NeoGenomics Beats Investor Suit Over Growth Driver Claims
By Emilie Ruscoe · March 17, 2026, 9:55 PM EDT
Cancer diagnostics company NeoGenomics Inc. no longer faces a proposed investor class action alleging it mischaracterized its growth drivers, including by failing to disclose that a rainmaking unit potentially ran afoul...
To view the full article, register now.